Should psychological distress be listed as a surgical indication for indeterminate pulmonary nodules: protocol for a prospective cohort study in real-world settings

Weitao Zhuang, Yong Tang, Wei Xu, Shujie Huang, Cheng Deng, Rixin Chen, Dongkun Zhang, Ceng Zeng, Dan Tian, Xiaosong Ben, Zihua Lan, Hansheng Wu, Zhen Gao, Mengdie Wang, Yali Chen, Qiuling Shi, Guibin Qiao, Weitao Zhuang, Yong Tang, Wei Xu, Shujie Huang, Cheng Deng, Rixin Chen, Dongkun Zhang, Ceng Zeng, Dan Tian, Xiaosong Ben, Zihua Lan, Hansheng Wu, Zhen Gao, Mengdie Wang, Yali Chen, Qiuling Shi, Guibin Qiao

Abstract

Background: Pulmonary nodules (PNs) are documented in up to 30% of computed tomography (CT) reports. PNs of indeterminate nature (IPN) have been reported to be associated with increased psychological distress and deterioration of the quality of life. Despite lack of solid evidence, severe anxiety or depression has been proposed to be one of the surgical indications in expert consensus for IPN management. So far, there is no established criterion to guide the decision-making process, or to ensure evidence-based management. This study aims to evaluate whether psychological distress could be a surgical indication for IPN, and to establish an evidence-based distress threshold for necessary surgical intervention.

Methods: This prospective observational study in real-world setting will involve an expected sample size of 1,253 IPN patients from the thoracic clinic of Guangdong Provincial People's Hospital. Web-based questionnaires powered by Wen Juan Xing (WJX) platform will be delivered to the patients for baseline data collection and psychological screening. Based on our pilot study, a total of 376 IPN patients with abnormal or borderline abnormal psychological states, as assessed by the Hospital Anxiety and Depression Scale (HADS), will be followed for 1 year before proceeding to the final analysis. The planned study period is from Jan 1, 2021, to Sept 30, 2022, and will entail two HADS assessments at baseline and follow-up. Sleep quality and indicators of healthcare-seeking behavior, such as the number of unplanned clinic visits or CT scans per year, will be used as anchors of psychological state. Patients who undergo surgical resection against the follow-up plan will be enrolled into a surgical group (expected n=94), while those who adhere to their plan will be automatically classified as a follow-up group after 1-year follow-up (expected n=282). Statistical measures such as independent-samples t-test and receiver operating characteristics (ROC) analysis will be used to assess the difference in psychological changes between the groups, and to generate an optimal threshold alerting surgical need. A Chi-square test or nonparametric test will be used to compare the baseline characteristics. Contributors to psychological burden and their effect sizes will be evaluated using general linear regression.

Discussion: To date, data on the psychological benefits of surgical resection of IPN remains scanty. Evidence-based procedure of patient selection using appropriate psychological screening tools is crucial in improving the quality of care and preventing overtreatment. This protocol describes the rationale and methodology to address this unmet clinical need using real-world data, aiming to bridge the gap between clinical guidelines and real-world practice.

Trial registration: ClinicalTrials.gov Identifier: NCT04857333. Registered April 23, 2021.

Keywords: Pulmonary nodule (PN); clinical protocol; psychological burden; surgical indication.

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-21-1423/coif). All authors report funding from the 2020 Guangdong Provincial Special Project for Popularization of Science and Technology Innovation (grant number: 2020A1414070007). The authors have no other conflicts of interest to declare.

2022 Journal of Thoracic Disease. All rights reserved.

Figures

Figure 1
Figure 1
Flowchart of the study design. HADS, Hospital Anxiety and Depression Scale; PSQI, Pittsburgh Sleep Quality Index.
Figure 2
Figure 2
Patient selection diagram of the pilot study. PNs, pulmonary nodules; IPNs, indeterminate pulmonary nodules; HADS, Hospital Anxiety and Depression Scale.

References

    1. National Lung Screening Trial Research Team ; Church TR, Black WC, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980-91. 10.1056/NEJMoa1209120
    1. Zheng C, Huang BZ, Agazaryan AA, et al. Natural Language Processing to Identify Pulmonary Nodules and Extract Nodule Characteristics From Radiology Reports. Chest 2021;160:1902-14. 10.1016/j.chest.2021.05.048
    1. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology 2017;284:228-43. 10.1148/radiol.2017161659
    1. Wu GX, Raz DJ, Brown L, et al. Psychological Burden Associated With Lung Cancer Screening: A Systematic Review. Clin Lung Cancer 2016;17:315-24. 10.1016/j.cllc.2016.03.007
    1. Bauml JM, Troxel A, Epperson CN, et al. Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety". Lung Cancer 2016;100:110-3. 10.1016/j.lungcan.2016.08.002
    1. Slatore CG, Wiener RS, Golden SE, et al. Longitudinal Assessment of Distress among Veterans with Incidental Pulmonary Nodules. Ann Am Thorac Soc 2016;13:1983-91. 10.1513/AnnalsATS.201607-555OC
    1. Slatore CG, Sullivan DR, Pappas M, et al. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol 2014;9:927-34. 10.1097/JTO.0000000000000210
    1. Quaife SL, Janes SM, Brain KE. The person behind the nodule: a narrative review of the psychological impact of lung cancer screening. Transl Lung Cancer Res 2021;10:2427-40. 10.21037/tlcr-20-1179
    1. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making 2008;28:917-25. 10.1177/0272989X08322013
    1. van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br J Cancer 2010;102:27-34. 10.1038/sj.bjc.6605459
    1. van den Bergh KA, Essink-Bot ML, Borsboom GJ, et al. Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial. Eur Respir J 2011;38:154-61. 10.1183/09031936.00123410
    1. Sodickson A, Baeyens PF, Andriole KP, et al. Recurrent CT, cumulative radiation exposure, and associated radiation-induced cancer risks from CT of adults. Radiology 2009;251:175-84. 10.1148/radiol.2511081296
    1. McCunney RJ, Li J. Radiation Risks in Lung Cancer Screening Programs. Chest 2014;145:618-24. 10.1378/chest.13-1420
    1. Jiang G, Chen C, Zhu Y, et al. Shanghai Pulmonary Hospital Experts Consensus on the Management of Ground-Glass Nodules Suspected as Lung Adenocarcinoma (Version 1). Zhongguo Fei Ai Za Zhi 2018;21:147-59.
    1. Annunziata MA, Muzzatti B, Bidoli E, et al. Hospital Anxiety and Depression Scale (HADS) accuracy in cancer patients. Support Care Cancer 2020;28:3921-6. 10.1007/s00520-019-05244-8
    1. Annunziata MA, Muzzatti B, Altoè G. Defining hospital anxiety and depression scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings. Ann Oncol 2011;22:2330-3. 10.1093/annonc/mdq750
    1. Brain K, Lifford KJ, Carter B, et al. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial. Thorax 2016;71:996-1005. 10.1136/thoraxjnl-2016-208283
    1. Kummer S, Waller J, Ruparel M, et al. Psychological outcomes of low-dose CT lung cancer screening in a multisite demonstration screening pilot: the Lung Screen Uptake Trial (LSUT). Thorax 2020;75:1065-73.
    1. Li Q, Lin Y, Hu C, et al. The Chinese version of hospital anxiety and depression scale: Psychometric properties in Chinese cancer patients and their family caregivers. Eur J Oncol Nurs 2016;25:16-23. 10.1016/j.ejon.2016.09.004
    1. Kaerlev L, Iachina M, Pedersen JH, et al. CT-Screening for lung cancer does not increase the use of anxiolytic or antidepressant medication. BMC Cancer 2012;12:188. 10.1186/1471-2407-12-188
    1. van den Bergh KA, Essink-Bot ML, Bunge EM, et al. Impact of computed tomography screening for lung cancer on participants in a randomized controlled trial (NELSON trial). Cancer 2008;113:396-404. 10.1002/cncr.23590
    1. Aggestrup LM, Hestbech MS, Siersma V, et al. Psychosocial consequences of allocation to lung cancer screening: a randomised controlled trial. BMJ Open 2012;2:e000663. 10.1136/bmjopen-2011-000663
    1. Esser P, Hartung TJ, Friedrich M, et al. The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients. Psychooncology 2018;27:1509-16. 10.1002/pon.4681
    1. Lambert SD, Pallant JF, Boyes AW, et al. A Rasch analysis of the Hospital Anxiety and Depression Scale (HADS) among cancer survivors. Psychol Assess 2013;25:379-90. 10.1037/a0031154

Source: PubMed

3
Subscribe